Podcast

Bruce Rollman, MD, on Depression in Heart Failure

01/21/2020

 

In this podcast, Bruce Rollman, MD, from the University of Pittsburgh, discusses the preliminary results of his Hopeful Heart Trial, a study in which enrolled depressed and non-depressed patients with heart failure to track quality of life in a blended care setting.

Bruce L. Rollman, MD, MPH, is the UPMC Endowed Chair in General Internal Medicine, director of the Center for Behavioral Health and Smart Technology, and professor of medicine in the Department of Psychiatry, Biomedical Informatics, and Clinical and Translational Science at the University of Pittsburgh in Pennsylvania. 

Additional Reading:

Related Content

Bacterial Infections
Bacterial Infections
Procalcitonin as a Marker for Sepsis
04/08/2022
He discusses procalcitonin as a marker for sepsis, how a procalcitonin test fares among other diagnostic tests, and how this testing can guide antibiotic stewardship.
04/08/2022
Multiple Sclerosis
Multiple Sclerosis
Ilya Kister, MD, on the MS Severity Score
04/08/2020
He discusses an article he wrote about the concept and applications of the multiple sclerosis disease severity score, introducing Herbert's Classification, and more.
04/08/2020
Infectious Diseases
Infectious Diseases
Titilola Labisi, MHA, MPH, on Viral Suppression Among Women Living With HIV
09/29/2021
In this podcast, Titilola Labisi, MHA, MPH, speaks about factors associated with lack of viral suppression among women living with HIV in the United States, including keys to preventing sexual transmission,...
09/29/2021
Stress and Burnout
Stress and Burnout
Bruce Y. Lee, MD, on the FDA’s Emergency Authorization of Remdesivir
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
HIV Management
HIV Management
Anandi Sheth, MD, MSc, on HIV Prevention in Women
05/20/2020
In this podcast, she discusses HIV prevention for women, specifically cisgender women and other underrepresented women.
05/20/2020